Research Output per year
Research Output 1981 2019
- 1 - 50 out of 273 results
- Publication Year, Title (descending)
2019
GEAMP, a novel gastroesophageal junction carcinoma cell line derived from a malignant pleural effusion
Zhang, W., Williams, T. A., Bhagwath, A. S., Hiermann, J. S., Peacock, C. D., Watkins, D. N., Ding, P., Park, J. Y., Montgomery, E. A., Forastiere, A. A., Jie, C., Cantarel, B. L., Pham, T. H. & Wang, D. H., Jan 1 2019, In : Laboratory Investigation.Research output: Contribution to journal › Article
Malignant Pleural Effusion
Esophagogastric Junction
Carcinoma
Cell Line
Neoplasms
Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature
Bossi, P., Alfieri, S., Strojan, P., Takes, R. P., López, F., Mäkitie, A., Saba, N. F., Rodrigo, J. P., Bradford, C., Suarez, C., Zafereo, M., Forastiere, A. A., Vermorken, J. B., Quer, M., Sanabria, A., Simo, R., de Bree, R., Rinaldo, A. & Ferlito, A., May 1 2019, In : Critical Reviews in Oncology/Hematology. 137, p. 84-91 8 p.Research output: Contribution to journal › Review article
Papillomaviridae
Therapeutics
Palliative Care
Immunotherapy
Caregivers
PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma
Eze, N., Lee, J. W., Yang, D. H., Zhu, F., Neumeister, V., Sandoval-Schaefer, T., Mehra, R., Ridge, J. A., Forastiere, A. A., Chung, C. H. & Burtness, B., Apr 1 2019, In : Oral Oncology. 91, p. 69-78 10 p.Research output: Contribution to journal › Article
Phosphatidylinositol 3-Kinases
Epidermal Growth Factor Receptor
Cisplatin
Biomarkers
Placebos
2018
Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States
Park, J. C., Gourin, C., Kiess, A. P., Mehra, R., Forastiere, A. A. & Kang, H., Jan 1 2018, (Accepted/In press) In : Head and Neck.Research output: Contribution to journal › Article
Population
Clinical Trials
Therapeutics
Carboplatin
Cisplatin
Phase II Study of Irinotecan Plus Panitumumab as Second-Line Therapy for Patients with Advanced Esophageal Adenocarcinoma
Yoon, H., Choudhary, A., Kosozi, R., Bali, G. S., Zaidi, A., Atasoy, A., Forastiere, A. A. & Forastiere, A. A., Jan 1 2018, (Accepted/In press) In : Oncologist.Research output: Contribution to journal › Article
irinotecan
Adenocarcinoma
Confidence Intervals
Fatigue
Therapeutics
Radiation therapy for oropharyngeal squamous cell carcinoma: American society of clinical oncology endorsement of the American society for radiation oncology evidence-Based clinical practice guideline summary
Quon, H., Vapiwala, N., Forastiere, A. A. & Kennedy, E. B., Feb 1 2018, In : Journal of Oncology Practice. 14, 2, p. 117-122 6 p.Research output: Contribution to journal › Article
Radiation Oncology
Medical Oncology
Evidence-Based Practice
Practice Guidelines
Squamous Cell Carcinoma
Reply to L. Licitra et al
Forastiere, A. A., Fisher, S. G. & Wolf, G. T., May 1 2018, In : Journal of Clinical Oncology. 36, 13, p. 1377-1378 2 p.Research output: Contribution to journal › Letter
Use of larynx-preservation strategies in the treatment of laryngeal cancer: American society of clinical oncology clinical practice guideline update
Forastiere, A. A., Ismaila, N., Lewin, J. S., Nathan, C. A., Adelstein, D. J., Eisbruch, A., Fass, G., Fisher, S. G., Laurie, S. A., Le, Q. T., O'Malley, B., Mendenhall, W. M., Patel, S., Pfister, D. G., Provenzano, A. F., Weber, R., Weinstein, G. S. & Wolf, G. T., Apr 10 2018, In : Journal of Clinical Oncology. 36, 11, p. 1143-1169 27 p.Research output: Contribution to journal › Review article
Laryngeal Neoplasms
Medical Oncology
Larynx
Practice Guidelines
Laryngectomy
Use of larynx-Preservation strategies in the treatment of laryngeal cancer: American society of clinical oncology clinical practice guideline update summary
Forastiere, A. A., Ismaila, N. & Wolf, G. T., Feb 1 2018, In : Journal of Oncology Practice. 14, 2, p. 123-128 6 p.Research output: Contribution to journal › Article
Laryngeal Neoplasms
Medical Oncology
Larynx
Practice Guidelines
2017
Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trials
Sanabria, A., Chaves, A. L. F., Kowalski, L. P., Wolf, G. T., Saba, N. F., Forastiere, A. A., Beitler, J. J., Nibu, K. I., Bradford, C. R., Suárez, C., Rodrigo, J. P., Strojan, P., Rinaldo, A., de Bree, R., Haigentz, M., Takes, R. P. & Ferlito, A., Feb 1 2017, In : Auris Nasus Larynx. 44, 1, p. 18-25 8 p.Research output: Contribution to journal › Review article
Organ Preservation
Laryngeal Neoplasms
Randomized Controlled Trials
Laryngectomy
Selection Bias
Radiation therapy for oropharyngeal squamous cell carcinoma: American Society of Clinical Oncology endorsement of the American Society for Radiation Oncology evidence-based Clinical Practice guideline
Quon, H., Vapiwala, N., Forastiere, A. A., Kennedy, E. B., Adelstein, D. J., Boykin, H., Califano, J. A., Holsinger, F. C., Nussenbaum, B., Rosenthal, D. I., Siu, L. L. & Waldron, J. N., Dec 20 2017, In : Journal of Clinical Oncology. 35, 36, p. 4078-4090 13 p.Research output: Contribution to journal › Article
Radiation Oncology
Medical Oncology
Evidence-Based Practice
Practice Guidelines
Squamous Cell Carcinoma
Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond
de Bree, R., Wolf, G. T., de Keizer, B., Nixon, I. J., Hartl, D. M., Forastiere, A. A., Haigentz, M., Rinaldo, A., Rodrigo, J. P., Saba, N. F., Suárez, C., Vermorken, J. B. & Ferlito, A., Nov 1 2017, In : Head and Neck. 39, 11, p. 2329-2349 21 p.Research output: Contribution to journal › Review article
Induction Chemotherapy
Physical Examination
Radiotherapy
Radiation
Head and Neck Neoplasms
2016
Biomarkers in head and neck cancer
Kang, H., Chung, C. H. & Forastiere, A. A., Jan 1 2016, Head and Neck Cancer: Multimodality Management, Second Edition. Springer International Publishing, p. 149-162 14 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
Head and Neck Neoplasms
Biomarkers
Genomics
Allergy and Immunology
Palliative Care
Eastern cooperative oncology group and american college of radiology imaging network randomized phase 2 trial of neoadjuvant preoperative paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design
Kleinberg, L. R., Catalano, P. J., Forastiere, A. A., Keller, S. M., Mitchel, E. P., Anne, P. R. & Benson, A. B., Mar 15 2016, In : International Journal of Radiation Oncology, Biology, Physics. 94, 4, p. 738-746 9 p.Research output: Contribution to journal › Article
irinotecan
radiology
Radiology
Cisplatin
radiation therapy
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
Marur, S. & Forastiere, A. A., Mar 1 2016, In : Mayo Clinic Proceedings. 91, 3, p. 386-396 11 p.Research output: Contribution to journal › Article
Head and Neck Neoplasms
Epidemiology
Oropharyngeal Neoplasms
Squamous Cell Neoplasms
Oropharynx
2015
Organ preservation for advanced larynx cancer: Issues and outcomes
Forastiere, A. A., Weber, R. S. & Trotti, A., Oct 10 2015, In : Journal of Clinical Oncology. 33, 29, p. 3262-3268 7 p.Research output: Contribution to journal › Article
Organ Preservation
Laryngeal Neoplasms
Laryngectomy
Induction Chemotherapy
Larynx
Patients and physicians can discuss costs of cancer treatment in the clinic
Kelly, R. J., Forde, P., Elnahal, S. M., Forastiere, A. A., Rosner, G. & Smith, T. J., Jul 1 2015, In : Journal of Oncology Practice. 11, 4, p. 308-312 5 p.Research output: Contribution to journal › Article
Health Care Costs
Physicians
Costs and Cost Analysis
Neoplasms
Emotions
Predicting survival in head and neck squamous cell carcinoma from TP53 mutation
Masica, D. L., Li, S., Douville, C., Manola, J., Ferris, R. L., Burtness, B., Forastiere, A. A., Koch, W. M., Chung, C. H. & Karchin, R., May 1 2015, In : Human Genetics. 134, 5, p. 497-507 11 p.Research output: Contribution to journal › Article
Mutation
Survival
Disease-Free Survival
Carcinoma, squamous cell of head and neck
Tumor Suppressor Protein p53
Quality of care and short- and long-term outcomes of laryngeal cancer care in the elderly
Gourin, C., Starmer, H. M., Herbert, R. J., Frick, K., Forastiere, A. A., Quon, H., Eisele, D. W. & Dy, S. E., Oct 1 2015, In : Laryngoscope. 125, 10, p. 2323-2329 7 p.Research output: Contribution to journal › Article
Laryngeal Neoplasms
Quality of Health Care
Odds Ratio
Squamous Cell Neoplasms
Airway Obstruction
Short-and long-term outcomes of laryngeal cancer care in the elderly
Gourin, C., Starmer, H. M., Herbert, R. J., Frick, K., Forastiere, A. A., Eisele, D. W. & Quon, H., Apr 1 2015, In : Laryngoscope. 125, 4, p. 924-933 10 p.Research output: Contribution to journal › Article
Laryngeal Neoplasms
Odds Ratio
Deglutition Disorders
Pneumonia
Airway Obstruction
When is chemotherapy in head and neck squamous cell carcinoma not indicated?
Haigentz, M., Vermorken, J. B., Forastiere, A. A., Corry, J., Beitler, J. J., Strojan, P., Hartl, D. M., Rodrigo, J. P., Bradford, C. R., Rinaldo, A., Takes, R. P., Mendenhall, W. M., Shaha, A. R., Wolf, G. T. & Ferlito, A., Apr 1 2015, In : European Archives of Oto-Rhino-Laryngology. 272, 4, p. 781-787 7 p.Research output: Contribution to journal › Article
2014
A 30-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Chung, C. H., Lee, J. W., Slebos, R. J., Howard, J. D., Perez, J., Kang, H., Fertig, E., Considine, M., Gilbert, J., Murphy, B. A., Nallur, S., Paranjape, T., Jordan, R. C., Garcia, J., Burtness, B., Forastiere, A. A. & Weidhaas, J. B., Nov 1 2014, In : Annals of Oncology. 25, 11, p. 2230-2236 7 p.Research output: Contribution to journal › Article
Untranslated Regions
Cisplatin
Oropharynx
Platinum
Cell Line
Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)
Wanebo, H. J., Lee, J., Burtness, B. A., Ridge, J. A., Ghebremichael, M., Spencer, S. A., Psyrri, D., Pectasides, E., Rimm, D., Rosen, F. R., Hancock, M. R., Tolba, K. A. & Forastiere, A. A., Oct 1 2014, In : Annals of Oncology. 25, 10, p. 2036-2041 6 p.Research output: Contribution to journal › Article
Carboplatin
Head and Neck Neoplasms
Paclitaxel
Biopsy
Survival
Phase II study of cetuximab in combination with cisplatin and radiation in Unresectable, locally advanced head and neck squamous cell carcinoma: Eastern Cooperative Oncology Group Trial E3303
Marie Egloff, A., Lee, J. W., Langer, C. J., Quon, H., Vaezi, A., Grandis, J. R., Seethala, R. R., Wang, L., Shin, D. M., Argiris, A., Yang, D., Mehra, R., Andrew Ridge, J., Patel, U. A., Burtness, B. A. & Forastiere, A. A., Oct 1 2014, In : Clinical Cancer Research. 20, 19, p. 5041-5051 11 p.Research output: Contribution to journal › Article
Cisplatin
Radiation
Survival
Disease-Free Survival
Radiotherapy
Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern Cooperative Oncology Group E2303
Psyrri, A., Lee, J. W., Pectasides, E., Vassilakopoulou, M., Kosmidis, E. K., Burtness, B. A., Rimm, D. L., Wanebo, H. J. & Forastiere, A. A., Jun 1 2014, In : Clinical Cancer Research. 20, 11, p. 3023-3032 10 p.Research output: Contribution to journal › Article
Squamous Cell Neoplasms
Head and Neck Neoplasms
Disease-Free Survival
Biomarkers
Head
Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: An analysis of Eastern Cooperative Oncology Group trials
Argiris, A., Li, S., Ghebremichael, M., Egloff, A. M., Wang, L., Forastiere, A. A., Burtness, B. & Mehra, R., 2014, In : Annals of Oncology. 25, 7, p. 1410-1416 7 p., mdu167.Research output: Contribution to journal › Article
Head and Neck Neoplasms
irinotecan
Survival
docetaxel
In Situ Hybridization
Quality indicators of laryngeal cancer care in the elderly
Gourin, C., Frick, K., Blackford, A. L., Herbert, R. J., Quon, H., Forastiere, A. A., Eisele, D. W. & Dy, S. E., 2014, In : Laryngoscope. 124, 9, p. 2049-2056 8 p.Research output: Contribution to journal › Article
Laryngeal Neoplasms
Quality of Health Care
Survival
Squamous Cell Neoplasms
Terminal Care
Treatment, survival, and costs of laryngeal cancer care in the elderly
Gourin, C., Dy, S. E., Herbert, R. J., Blackford, A. L., Quon, H., Forastiere, A. A., Eisele, D. W. & Frick, K., 2014, In : Laryngoscope. 124, 8, p. 1827-1835 9 p.Research output: Contribution to journal › Article
Laryngeal Neoplasms
Health Care Costs
Survival
Costs and Cost Analysis
Confidence Intervals
2013
Cancer of the Esophagus
Kleinberg, L. R., Kelly, R. J., Yang, S. C., Wang, J. S. & Forastiere, A. A., Oct 22 2013, Abeloff's Clinical Oncology: Fifth Edition. Elsevier Inc., p. 1207-1239.e7Research output: Chapter in Book/Report/Conference proceeding › Chapter
Esophageal Neoplasms
Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma
Strojan, P., Haigentz, M., Bradford, C. R., Wolf, G. T., Hartl, D. M., Langendijk, J. A., Rinaldo, A., Eisbruch, A., Mendenhall, W. M., Forastiere, A. A., Takes, R. P. & Ferlito, A., Apr 2013, In : Oral Oncology. 49, 4, p. 283-286 4 p.Research output: Contribution to journal › Article
Combined Modality Therapy
Laryngectomy
Laryngeal Neoplasms
Chemoradiotherapy
Antineoplastic Agents
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): An open-label phase 3 randomised trial
Vermorken, J. B., Stöhlmacher-Williams, J., Davidenko, I., Licitra, L., Winquist, E., Villanueva, C., Foa, P., Rottey, S., Skladowski, K., Tahara, M., Pai, V. R., Faivre, S., Blajman, C. R., Forastiere, A. A., Stein, B. N., Oliner, K. S., Pan, Z. & Bach, B. A., Jul 2013, In : The Lancet Oncology. 14, 8, p. 697-710 14 p.Research output: Contribution to journal › Article
Fluorouracil
Cisplatin
Control Groups
Survival
panitumumab
Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: A cooperative group correlative study
Roh, J. L., Wang, X. V., Manola, J., Sidransky, D., Forastiere, A. A. & Koch, W. M., May 1 2013, In : Clinical Cancer Research. 19, 9, p. 2528-2540 13 p.Research output: Contribution to journal › Article
Head and Neck Neoplasms
Methylation
Genes
Neoplasms
Suppressor Genes
Controversies in treatment deintensification of human papillomavirus- associated oropharyngeal carcinomas: Should we, how should we, and for whom?
Quon, H. & Forastiere, A. A., Feb 10 2013, In : Journal of Clinical Oncology. 31, 5, p. 520-522 3 p.Research output: Contribution to journal › Article
Alphapapillomavirus
Local Neoplasm Recurrences
Antineoplastic Combined Chemotherapy Protocols
Oropharyngeal Neoplasms
Papillomavirus Infections
Induction chemotherapy meta-analysis in head and neck cancer: Right answer, wrong question
Forastiere, A. A., Adelstein, D. J. & Manola, J., Aug 10 2013, In : Journal of Clinical Oncology. 31, 23, p. 2844-2846 3 p.Research output: Contribution to journal › Article
Antineoplastic Combined Chemotherapy Protocols
Induction Chemotherapy
Head and Neck Neoplasms
Meta-Analysis
Is open surgery for head and neck cancers truly declining?
Hartl, D. M., Brasnu, D. F., Shah, J. P., Hinni, M. L., Takes, R. P., Olsen, K. D., Kowalski, L. P., Rodrigo, J. P., Strojan, P., Wolf, G. T., Rinaldo, A., Suárez, C., Mendenhall, W. M., Paleri, V., Forastiere, A. A., Werner, J. A. & Ferlito, A., Nov 2013, In : European Archives of Oto-Rhino-Laryngology. 270, 11, p. 2793-2802 10 p.Research output: Contribution to journal › Article
Head and Neck Neoplasms
Neoplasms
Skull Base
Technology
Mouth
Long-term results of RTOG 91-11: A comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer
Forastiere, A. A., Zhang, Q., Weber, R. S., Maor, M. H., Goepfert, H., Pajak, T. F., Morrison, W., Glisson, B., Trotti, A., Ridge, J. A., Thorstad, W., Wagner, H., Ensley, J. F. & Cooper, J. S., Mar 1 2013, In : Journal of Clinical Oncology. 31, 7, p. 845-852 8 p.Research output: Contribution to journal › Article
Laryngeal Neoplasms
Larynx
Radiotherapy
Therapeutics
Cisplatin
Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): A trial of the Eastern Cooperative Oncology Group
Gilbert, J., Lee, J. W., Argiris, A., Haigentz, M., Feldman, L. E., Jang, M., Arun, P., Van Waes, C. & Forastiere, A. A., Jul 2013, In : Head and Neck. 35, 7, p. 942-948 7 p.Research output: Contribution to journal › Article
irinotecan
Proteasome Inhibitors
Arm
Head and Neck Neoplasms
Bortezomib
Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: An eastern cooperative oncology group trial
Argiris, A., Ghebremichael, M., Gilbert, J., Lee, J. W., Sachidanandam, K., Kolesar, J. M., Burtness, B. & Forastiere, A. A., Apr 10 2013, In : Journal of Clinical Oncology. 31, 11, p. 1405-1414 10 p.Research output: Contribution to journal › Article
docetaxel
Head and Neck Neoplasms
Randomized Controlled Trials
Placebos
Epidermal Growth Factor Receptor
Reply to E.G. Russi et al and R. Haddad
Forastiere, A. A., Zhang, Q., Weber, R. S. & Ridge, J. A., Sep 1 2013, In : Journal of Clinical Oncology. 31, 25, p. 3171 1 p.Research output: Contribution to journal › Article
Laryngeal Neoplasms
2012
A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck
Gilbert, J., Rudek-Renaut, M., Higgins, M. J., Zhao, M., Bienvenu, S., Tsottles, N., Wahl, R., Forastiere, A. A. & Gillison, M., Mar 15 2012, In : Clinical Cancer Research. 18, 6, p. 1735-1742 8 p.Research output: Contribution to journal › Article
Chemoradiotherapy
Cisplatin
Radiotherapy
Maximum Tolerated Dose
Epidermal Growth Factor Receptor
Correction: A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck (Clinical Cancer Research (2012) 18, (1735-1742))
Gilbert, J., Rudek-Renaut, M., Higgins, M. J., Zhao, M., Bienvenu, S., Tsottles, N., Chaudhry, M. A., Wahl, R., Forastiere, A. A. & Gillison, M., Jul 15 2012, In : Clinical Cancer Research. 18, 14, p. 3998 1 p.Research output: Contribution to journal › Article
Chemoradiotherapy
Head and Neck Neoplasms
Squamous Cell Carcinoma
Research
Erlotinib Hydrochloride
Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer
Sanguineti, G., Sormani, M. P., Marur, S., Gunn, G. B., Rao, N., Cianchetti, M., Ricchetti, F., McNutt, T., Wu, B. & Forastiere, A. A., May 1 2012, In : International Journal of Radiation Oncology, Biology, Physics. 83, 1, p. 235-242 8 p.Research output: Contribution to journal › Article
Oropharyngeal Neoplasms
Mucositis
chemotherapy
radiation therapy
Radiotherapy
Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: An RTOG analysis
Machtay, M., Moughan, J., Farach, A., Martin-O'Meara, E., Galvin, J., Garden, A. S., Weber, R. S., Cooper, J. S., Forastiere, A. A. & Ang, K. K., Nov 15 2012, In : International Journal of Radiation Oncology, Biology, Physics. 84, 4, p. 983-989 7 p.Research output: Contribution to journal › Article
Radiation Oncology
Head and Neck Neoplasms
toxicity
radiation therapy
Radiotherapy
Long-term follow-up of the RTOG 9501/intergroup phase III trial: Postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck
Cooper, J. S., Zhang, Q., Pajak, T. F., Forastiere, A. A., Jacobs, J., Saxman, S. B., Kish, J. A., Kim, H. E., Cmelak, A. J., Rotman, M., Lustig, R., Ensley, J. F., Thorstad, W., Schultz, C. J., Yom, S. S. & Ang, K. K., Dec 1 2012, In : International Journal of Radiation Oncology, Biology, Physics. 84, 5, p. 1198-1205 8 p.Research output: Contribution to journal › Article
chemotherapy
radiation therapy
Radiotherapy
cancer
Drug Therapy
Reply to D.C. Gilbert et al
Mroz, E. A., Forastiere, A. A. & Rocco, J. W., Mar 10 2012, In : Journal of Clinical Oncology. 30, 8, p. 891-892 2 p.Research output: Contribution to journal › Article
Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia
Adelstein, D. J., Ridge, J. A., Brizel, D. M., Holsinger, F. C., Haughey, B. H., O'Sullivan, B., Genden, E. M., Beitler, J. J., Weinstein, G. S., Quon, H., Chepeha, D. B., Ferris, R. L., Weber, R. S., Movsas, B., Waldron, J., Lowe, V., Ramsey, S., Manola, J., Yueh, B., Carey, T. E. & 7 others, , Dec 2012, In : Head and Neck. 34, 12, p. 1681-1703 23 p.Research output: Contribution to journal › Article
Pharyngeal Neoplasms
National Cancer Institute (U.S.)
Head and Neck Neoplasms
Clinical Trials
Oropharyngeal Neoplasms
Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapy
Sanguineti, G., Ricchetti, F., Wu, B., Agrawal, N., Gourin, C., Agbahiwe, H., Marur, S., Clemente, S., McNutt, T. & Forastiere, A. A., Nov 2012, In : Head and Neck. 34, 11, p. 1640-1647 8 p.Research output: Contribution to journal › Article
Neck
Radiotherapy
Lymph Nodes
Therapeutics
Drug Therapy
2011
Activity of XL184 (cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer
Kurzrock, R., Sherman, S. I., Ball, D. W., Forastiere, A. A., Cohen, R. B., Mehra, R., Pfister, D. G., Cohen, E. E. W., Janisch, L., Nauling, F., Hong, D. S., Ng, C. S., Ye, L., Gagel, R. F., Frye, J., Müller, T., Ratain, M. J. & Salgia, R., Jul 1 2011, In : Journal of Clinical Oncology. 29, 19, p. 2660-2666 7 p.Research output: Contribution to journal › Article
Protein-Tyrosine Kinases
Vascular Endothelial Growth Factor Receptor-2
Mucositis
Maximum Tolerated Dose
cabozantinib
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: A trial of the Eastern Cooperative Oncology Group (E1303)
Argiris, A., Ghebremichael, M., Burtness, B., Axelrod, R. S., Deconti, R. C. & Forastiere, A. A., Aug 1 2011, In : Cancer. 117, 15, p. 3374-3382 9 p.Research output: Contribution to journal › Article
Adenoid Cystic Carcinoma
Doxorubicin
Neck
Head
Bortezomib
Erratum: Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care (Laryngoscope (2011) 121 (85-90))
Gourin, C., Forastiere, A. A., Sanguineti, G., Koch, W. M., Marur, S. & Bristow, R. E., Feb 2011, In : Laryngoscope. 121, 2, p. 457 1 p.Research output: Contribution to journal › Article
Laryngoscopes
Laryngeal Neoplasms
Costs and Cost Analysis
Surgeons